ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

A One-of-a-Kind Lifeline: A First Responder's Kidney Health Journey

By: NewsUSA

(NewsUSA) - Like the more than 25 million first responders in the United States, Jeff Cooper, a former deputy in the Broward County Polygraph Unit, took an oath to protect and serve his community. However, like many first responders, Cooper's promise did not necessarily extend to himself -- until a worsening medical condition forced him to focus on his health.

Polycystic Kidney Disease (PKD) affects more than seven million people worldwide, and in 1975 Cooper became one of those impacted by the disease. His PKD diagnosis, a hereditary condition, took him on a journey that would not only give him access to an innovative new technology, but would also allow him to experience remarkable camaraderie that would eventually stretch beyond the oath to protect and serve.

A Lifeline for Patients with End-Stage Renal Disease

PKD is a genetic disorder that causes cysts to develop on the kidneys -- making them enlarge and lose function. This hereditary condition can lead to the final stage of chronic kidney disease, also known as "end-stage renal disease." This condition requires more than 70% of patients to undergo dialysis -- a process of removing waste products and flushing excess fluid from the blood to keep kidneys functioning and patients alive -- or undergo a kidney transplant.

Before receiving dialysis, some patients undergo a procedure that creates an access point to their bloodstream, often referred to as a lifeline for dialysis, Arteriovenous (AV) fistulas are created by connecting a vein and artery in the arm, allowing the patient to begin dialysis.

Growing up with a father who underwent dialysis for many years, Cooper saw the side effects of the common, surgically created fistulas on his father's arms (like large, swollen veins) and hoped for a less invasive option that would allow him to continue his normal, active life.

While working with his doctor, Cooper discovered the Ellipsys® Vascular Access System -- a less invasive option for creating AV fistulas that's done through an out-patient procedure. While potential risks associated with creation and maintenance of arteriovenous fistula exist, the Ellipsys procedure can cut the time between fistula creation to dialysis from six months to two months, potentially translating into accelerated dialysis treatment.

A New Outlook, Another Miracle

Cooper received his Ellipsys- created fistula on December 4, 2020, giving him access to life-saving dialysis. Cooper said he was amazed at how fast he could return to everyday activities after the Ellipsys procedure.

After only a few months of adjusting to his new fistula and starting treatment, Cooper received another life-changing surprise. In early February 2021, Guy Kitchens -- coincidentally, a police officer in a neighboring county --gave his fellow officer the ultimate gift -- Kitchens donated his kidney to Cooper. Thanks to Officer Kitchens, Cooper says he feels like a kid again. His kidney function is improving, his doctors are dialing back his medications, and best of all, he's formed a lifelong friendship with Guy, with whom he talks almost daily.

"I've got a little brother now and another extended family," Cooper says. "I've got a living angel in my life."

Without his Ellipsys created fistula and dialysis treatment leading up to that life-changing day in February, Cooper's story might have been more challenging. Please consult with your doctor to see if this procedure is right for you -- results may vary. If you or someone you know is on a dialysis journey, learn more about the Ellipsys procedure, and associated risks, at: www.medtronic.com/Ellipsys.

 

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.